NVS · Novartis AG · Investor Relations
$160.50
+0.25 (+0.16%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$303.12B
Shares
1.89B
Volume · Nov 13
1.42M
Avg daily vol (3M)
2.11M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 00:00 UTC | Jefferies Global Healthcare Conference | Conference |
| 2026-11-19 00:00 UTC | Meet Novartis Management 2026 | Event |
| 2026-11-25 00:00 UTC | Berenberg CFO Call series | Event |
| 2026-12-01 00:00 UTC | Citi Global Healthcare Conference | Conference |
| 2026-12-07 00:00 UTC | Bank of America R&D call series | Event |
| 2026-12-09 00:00 UTC | Deutsche Bank C-Suite call series | Event |
| 2027-01-11 00:00 UTC | J.P. Morgan Healthcare Conference | Conference |
| 2027-02-03 00:00 UTC | Novartis 2026 Financial Results | Results publication |
| 2027-03-05 00:00 UTC | Annual General Meeting 2027 | Shareholder meeting |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-10 | UBS European Conference | Conference |
| 2026-11-10 | Guggenheim Healthcare Innovation Conference | Conference |
| 2026-11-05 | ZKB Swiss Equity Conference | Conference |
| 2026-10-27 | Q3 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
| 2026-10-27 | Novartis Financial Results - Q3 2026 | Event |
| 2026-10-23 | Remibrutinib in MS Investor Call | Event |
| 2026-07-21 | Novartis Q2 2026 Results Release | Earnings call |
| 2026-04-28 | Novartis Q1 2026 Results Release | Earnings call |
| 2026-02-04 | Novartis Q4 2025 Results Release | Earnings call |
| 2025-10-28 | Novartis Q3 2025 Results Release | Earnings call |
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
1276 filings
1161 filers
Visit website
Investor relations